Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c1142 |
|---|---|
| Identifier | NCT06786507 |
| Trial Title | A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Ustekinumab 90 mg|DRUG: Infliximab |
Participant Information
| Sponsor | Helwan University |
|---|---|
| City | Cairo |
| Country/Region | Egypt |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-05-15 |
|---|---|
| Primary Completion Date | 2026-06-01 |
| Completion Date | 2026-10-01 |